trending Market Intelligence /marketintelligence/en/news-insights/trending/CEX2WJWJy_3STk0zP2vRig2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Novartis names CEO of oncology unit

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Novartis names CEO of oncology unit

Novartis AG said Susanne Schaffert, president of its unit Advanced Accelerator Applications SA, will become CEO of Novartis Oncology, effective Jan. 1.

Schaffert has been with the Swiss pharmaceutical giant for over 20 years and has held leadership roles in the oncology unit for the past six years.

She will replace Liz Barrett, who will step down as CEO of the oncology unit, effective Dec. 31.

Barrett, who became head of Novartis Oncology on Feb. 1, said she is leaving because her family will be unable to relocate to Basel, Switzerland, where the unit is based. Barrett will join a U.S.-based biotechnology company as CEO.